文献速递乳腺US

双激活TiO2-Au纳米杂化体用于非侵入性光热-声动力治疗:一种替代侵入性放疗的竞争性方案

A Non-Invasive Combined Photothermal-Sonodynamic Therapy Using a Dual-Activated TiO2-Au Nanohybrid: A Competitive Alternative to the Invasive Radiotherapy.
PubMed 文献 · Ultrasound Med Biol · 2026-04-05

该研究合成TiO2-Au纳米杂化体,在近红外光和超声双激活下对MCF-7乳腺癌细胞实现协同光热-声动力治疗(SDPTT),细胞活力降至38.4%,与放疗联合纳米杂化体(37.9%)相当且优于单独放疗(72.1%),提示该非电离策略有望成为安全可重复的乳腺癌治疗补充方案,但尚需更多临床前验证。

要点

  • TiO2-Au纳米杂化体需近红外光与超声双激活才能显著杀伤乳腺癌细胞。
  • 双激活SDPTT的细胞活力抑制程度与放疗联合纳米杂化体相当。
  • 该策略为非电离、可重复的微创治疗,但仅限体外细胞实验。
英文原文(摘要)· 点击展开

BACKGROUND: Conventional radiotherapy (RT) is widely used to treat breast cancer (BC), although its use has been limited by ionizing damage and low repeatability. This study proposes a dual-activated, non-ionizing treatment strategy using TiO2-Au nanohybrids (NHs), triggered by near-infrared (NIR) light and ultrasound (US), to induce synergistic sonodynamic-photothermal therapy (SDPTT) as a minimally invasive alternative with therapeutic efficacy comparable to conventional radiotherapy (RT).

METHODS: TiO2-Au NHs were synthesized and thoroughly characterized using FESEM, TEM, UV-vis spectroscopy, zeta potential, and EDS analysis. Afterward, TiO2-Au NHs (50 μg mL-1) were used to treat MCF-7 BC cells with NIR, US, or both. MTT assays were performed to determine cell viability. DCFH-DA staining was applied to visualize ROS production. In following, MCF-7 BC cells as RT groups were treated with X-ray (4 Gy) with or without TiO2-Au NHs and MTT and ROS assays were conducted. Combination indices (CI) analysis was used to quantify synergy.

RESULTS: NIR or US alone had modest cytotoxicity, with viability of 74.3% and 78.2%, respectively. In the presence of TiO2-Au NHs, dual activation (SDPTT) significantly reduced viability to 38.4% (p < 0.01), accompanied by the highest ROS levels. This effect was comparable to RT + NH (37.9%) and superior to RT alone (72.1%). CI analysis revealed synergy in SDPTT (CI = 1.26) and RT + TiO2-Au NHs (CI = 1.44).

CONCLUSION: While radiotherapy stands as a well-established treatment method effective through ionizing radiation, TiO2-Au-mediated SDPTT introduces a supplemental non-ionizing strategy that combines heat generation with oxidative stress. The dual-activated nanostructure holds potential for safe and repeatable BC treatment, yet requires additional preclinical examination.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Faghani-Eskandarkolaei P, Perota G, Haghighi H, et al. A Non-Invasive Combined Photothermal-Sonodynamic Therapy Using a Dual-Activated TiO2-Au Nanohybrid: A Competitive Alternative to the Invasive Radiotherapy. Ultrasound Med Biol. 2026. PMID: 41936527. doi:10.1016/j.ultrasmedbio.2026.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。